ProShare Advisors’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $36.1K | Sell |
11,618
-803
| -6% | -$2.5K | ﹤0.01% | 2028 |
|
|
2025
Q1 | $42K | Sell |
12,421
-3,122
| -20% | -$10.6K | ﹤0.01% | 1969 |
|
|
2024
Q4 | $88.1K | Sell |
15,543
-8,311
| -35% | -$47.1K | ﹤0.01% | 2097 |
|
|
2024
Q3 | $140K | Buy |
+23,854
| New | +$140K | ﹤0.01% | 1819 |
|
|
2024
Q2 | – | Sell |
-10,876
| Closed | -$101K | – | 2016 |
|
|
2024
Q1 | $101K | Buy |
+10,876
| New | +$101K | ﹤0.01% | 1820 |
|
|
2021
Q2 | – | Sell |
-12,116
| Closed | -$57K | – | 2408 |
|
|
2021
Q1 | $57K | Buy |
12,116
+606
| +5% | +$2.85K | ﹤0.01% | 2219 |
|
|
2020
Q4 | $82K | Buy |
+11,510
| New | +$82K | ﹤0.01% | 2013 |
|
|
2020
Q1 | – | Sell |
-11,288
| Closed | -$157K | – | 1582 |
|
|
2019
Q4 | $157K | Sell |
11,288
-1,461
| -11% | -$20.3K | ﹤0.01% | 1639 |
|
|
2019
Q3 | $219K | Sell |
12,749
-272
| -2% | -$4.67K | ﹤0.01% | 1398 |
|
|
2019
Q2 | $354K | Sell |
13,021
-392
| -3% | -$10.7K | ﹤0.01% | 1156 |
|
|
2019
Q1 | $257K | Buy |
13,413
+137
| +1% | +$2.63K | ﹤0.01% | 1337 |
|
|
2018
Q4 | $125K | Sell |
13,276
-2,576
| -16% | -$24.3K | ﹤0.01% | 1447 |
|
|
2018
Q3 | $300K | Sell |
15,852
-557
| -3% | -$10.5K | ﹤0.01% | 1353 |
|
|
2018
Q2 | $321K | Sell |
16,409
-625
| -4% | -$12.2K | ﹤0.01% | 1346 |
|
|
2018
Q1 | $320K | Sell |
17,034
-2,804
| -14% | -$52.7K | ﹤0.01% | 1285 |
|
|
2017
Q4 | $329K | Buy |
+19,838
| New | +$329K | ﹤0.01% | 1336 |
|